Andre curiously browsed the order page.
This is a standalone ordering website called Ordergene, which operates as a global non-profit organization.
At the top there is an entry for 'How to Order', clicking which will bring up 'Order Instructions'.
The entire page is simple and beautiful, looks very professional, and the ordering process is very clear.
Any researcher anywhere in the world, with a computer or mobile phone, can order the samples they need with just a few clicks.
Over the next few days, the product will be delivered to the researcher's door, and the researcher will then simply need to combine it with the Guide RNA of the gene they want to cut.
Even this final step can be ordered through the website.
The whole process is similar to shopping online on Amazon.
Andre immediately clicked the mouse and attempted to place an order.
Orders can only be placed online in principle; orders placed by phone or other means cannot be accepted. Therefore, you must first register by filling in your personal information.
Andre clicked 'Register'. The first step was to select a country. After selecting the Eagle Country, he proceeded to the second step, 'Select Organization'. There were three options: research institution/non-profit organization, enterprise, or individual.
Out of curiosity, he tried selecting the 'research institution' option, and instantly a list of Eagle Country universities popped up. Scrolling down, he was surprised to see the school he graduated from.
Select the name of the school you graduated from, click OK, and a list of college names of the selected university will pop up.
After selecting a college, it even lists the names of the professors and associate professors working in that college.
Andre browsed through the list and found the name of his former mentor, then clicked to confirm.
Then you enter the final step, where you can enter your name, email address, and phone number to complete the registration.
The whole process was very smooth, and most importantly, it was able to list so many university professors' names.
He couldn't help but marvel, and then returned to the second step, selecting the 'Enterprise' option.
This time, the names that popped up were those of Eagle Country pharmaceutical and biotechnology companies such as Pfizer, Johnson & Johnson Eli Lilly, AbbVie, Biogen, and Genentech.
Andre chose Pfizer without hesitation, and a list of researchers' names appeared before him.
He was very familiar with these names; most of them were his colleagues, and some were even subordinates in his oncology department.
As expected, he saw his own name, clicked on it, and proceeded directly to the final step.
After successfully registering your account, you can proceed to the order page.
You can choose the version of the original bacterial protein you need, or you can customize the Guide RNA you need.
The former is free, but postage is required. The latter requires a certain amount depending on the needs, but the price is not expensive, usually under one hundred US dollars.
As for quantity, there are certain restrictions. Generally, an individual is limited to no more than 10 items per order, while an organization or enterprise is limited to no more than 50 items.
The website restricts orders to academic research in this way and provides only a limited number of free samples at a time.
If you want to use it for large-scale commercial applications, you can only purchase it from Three Purities through official channels.
If you have any questions during the ordering process, you can contact us via the email address and phone number provided on the website.
Next, click the 'Add to Cart' button, just like you would when shopping on Amazon.
After filling in a valid shipping address and paying the fee, the order is complete. The whole process is very convenient and quick.
Thanks to today's highly developed transportation and delivery system, once an order is received, the samples, which are divided into small test tubes, will be packed into cartons at some point that day and shipped to destinations around the world.
These cardboard boxes are all managed using barcodes, so that it's possible to trace which researcher in the world purchased the samples.
Business is booming, with the website receiving hundreds of orders from around the world every day, and then delivering samples to 38 countries and regions worldwide.
The entire website is essentially a 'trial' system, promoting easy-to-use Gene Editing tools to the world by giving them away for free.
In this way, any researcher can easily make a purchase and obtain the samples they need.
Andre took the final step and successfully placed an order in the company's name.
He plans to have the lab test the samples thoroughly after receiving them to see how effective they are in practice.
At the same time, it is also necessary to compare it with the Broad Institute's CRISPR-CAS 9 technology to see which is superior.
Although rumors were circulating everywhere that Three Purities's new technology was incredibly powerful and could outperform everything, he still had some doubts.
I wonder if this new technology is really as good as the rumors say?
Only by seeing it for himself can he be completely convinced.
******
A few days later, Andre received the samples at the company.
He then excitedly went to the Rare Disease Division and found the head of the laboratory.
"Duke. Duke, good news! I've brought you a gift that I'm sure you'll love."
Andre handed over the cardboard box he was holding.
Duke. Duke, with his gray hair, is over sixty years old, but he is still energetic and has bright eyes.
He took it with a puzzled look, and when he saw the letters 'Sanqing' on it, his expression changed immediately.
I immediately opened the cardboard box and saw a row of neatly arranged glass test tubes inside.
I picked up a glass test tube at random, and when I saw the English label on it, my eyes lit up with surprise and delight.
"Wow, Andre, your gift isn't Three Purities Arc1 Protein sample, is it? That's a huge surprise!"
Duke. Duke was overjoyed and led Andre straight to the laboratory, giving a long and detailed introduction as they went.
"We are currently conducting Gene Therapy research for Hemophilia and have made some progress, but we are still some distance from clinical trials."
"Our researchers isolated epithelial cells from the surface of the urinary tract in the urine of seven patients with severe Hemophilia A and reprogrammed them into induced pluripotent stem cells (iPS cells). The iPS cells were then Gene Editing to insert multiple copies of the normal factor VIII gene."
"After these endothelial cells are implanted subcutaneously into Hemophilia A mice, they form a vascular network. The blood vessels directly deliver functional factor VIII into the bloodstream, and the secreted proteins are sufficient to supply the whole body."
"The results were very encouraging. In mice that received endothelial cell transplantation, the circulating coagulation factor VIII increased by 600%, and normal coagulation was restored."
"Currently, this therapy has only been achieved in mouse models of Hemophilia A. As for experiments in human cells, due to the complexity of the procedures, the off-target rate is high and the success rate is not satisfactory when using CRISPR-CAS 9 technology for Gene Editing."
"However, since you've brought these treasures," Dr. Duke said with a smile, holding up the test tubes in his hand, his eyes full of anticipation.
"We hope that Three Purities's new gene technology can bring us new breakthroughs."
******
Two weeks later, Duke stared at the experimental results before him, dumbfounded and incredulous.
"Oh my God! A miracle! This must be a miracle!"
A series of gasps and screams came from behind him.
The researchers in the lab stared intently at the screen, looking completely bewildered, as if they had seen a ghost.
Dr. Duke, with his extensive experience, quickly recovered and coughed lightly, bringing everyone back to their senses.
"I can hardly believe that so many years of hard work have resulted in a qualitative breakthrough in just two weeks."
A senior researcher murmured, his face showing a complex mix of joy and frustration.
"If only we could have used Three Purities's gene technology sooner, our Hemophilia Gene Drug would have been on the market long ago, and patients could have been saved much sooner."
Another researcher looked downcast, lowered his head, and sighed, as if recalling some unpleasant memories.
Duke. Duke let out a hearty laugh, encouraging everyone, "It's not too late now, haha."
"Today is a wonderful day. Our Hemophilia Gene Drug has finally made progress in clinical trials, and we should celebrate it."
The crowd erupted in cheers, and people beamed with joy at the achievement.
Dr. Duke made arrangements for the follow-up work, took the experimental results, and left.
We must immediately report this exciting result to the company's senior management, expedite clinical trials, and strive for an early market launch.
He could already imagine that after Three Purities's fourth-generation gene technology was launched, Pfizer would not be the only company to achieve breakthroughs using it.
Bayer, Novartis, Biogen, Roche —these greedy and ambitious peers must also be in their labs, working tirelessly day and night, striving to overcome the challenges of developing Gene Drug.
With the support of new technologies, they will achieve breakthroughs faster and faster, and the competition will become increasingly fierce.
As the world's number one pharmaceutical company, Pfizer cannot afford to lose at the starting line, nor can it fall behind its competitors.
******
Pfizer headquarters building, New Village City, Eagle Country.
The spacious and bright office was now noisy, as bustling as a vegetable market.
Company executives and directors of various laboratories gathered together, whispering amongst themselves.
Pfizer CEO Albert looked around and gently tapped the table. "Gentlemen, quiet!"
Once everyone quieted down, he looked at Dr. Duke with a serious expression.
"Today, I have some good news to share: our laboratory has successfully developed Gene Drug for Hemophilia. Dr. Duke will explain the details later."
Duke. Duke nodded and recounted the whole story with great enthusiasm.
"This drug development is inseparable from Three Purities's gene technology. Our previous research had been slow to make a breakthrough until we used this new technology and achieved amazing results."
"After using this brand-new Gene Editing Technology, we conducted experiments on human cells, and the results were astonishing, simply perfect. Not only was the off-target rate greatly reduced, but the Gene Editing time was also greatly increased."
"IPS cells can complete Gene Editing in just a few hours, achieving the desired effect, perfectly transforming into healthy endothelial cells, and naturally secreting clotting factor VIII."
"Not only that, I also tried to inject gene fluid directly into human cells, and the Gene Editing effect was also excellent. This means that we can improve the way patients are injected with drugs, thereby achieving in vivo Gene Therapy."
"Mr. Albert, I suggest that this gene technology be promoted throughout the company. It will definitely greatly promote the research of Gene Drug for Rare Disease."
Dr. Duke became increasingly excited as he spoke, and then connected to the projector to begin displaying the experimental results.
The other executives and experts, their expressions shifting from doubt to surprise to shock, stared at the screen, dumbfounded.
Even after Duke. Duke finished speaking, the entire room remained in an eerie silence.
Albert slowly began to speak, "What do you think?"
"Ah~" An executive opened his mouth as if he wanted to say something, but found that his thoughts were disordered and he could not speak. He could only utter a few meaningless exclamations.
Another executive, his face flushed and eyes shining, excitedly raised his hand. "Everyone, this is great news! I completely agree with Dr. Duke's view. Such powerful Gene Editing Technology can greatly promote the research of Gene Drug, and it must be promoted as soon as possible."
"My God, this is absolutely the most ingenious masterpiece I've ever seen," someone exclaimed.
"That Sanqing Group is fucking awesome! But I'm sure we can take down these top-notch guys." Someone shook his head and cursed.
Suddenly, someone spoke up, "Have you forgotten something? We have a strategic cooperation agreement worth 1.5 billion with the Broad Institute."
The sound stopped abruptly, and everyone fell silent instantly, like ducks being choked.
Albert observed everyone's reactions and nodded helplessly, saying, "This is indeed a problem. I will report to the board and await their decision."
Before he could finish speaking, Dr. Duke retorted, "As a scientist, I know what the best technology is. I only want to use the most advanced tools. Tell me, why force everyone to ride in horse-drawn carriages when we can ride in airplanes?"
"Indeed, since new technologies can accelerate drug development and increase the success rate, there is no need to stick to old technologies. After all, if we are even a little late, we will miss out on huge sums of money!" Andre was also present and expressed his strong dissatisfaction.
When he first handed the sample to Duke. Duke, he didn't pay much attention to it; it was just an experiment out of curiosity.
To my utter surprise, such a stunning result was achieved.
How could this be? People only told him this thing was useful, but they didn't tell him it would be this useful!
He almost immediately thought of the huge revenue that the previous collaboration on Anti-cancer Drug had brought to the company.
A surge of excitement welled up within him, and he immediately sensed yet another opportunity to curry favor with a powerful patron.
Last time, he seized the opportunity and his career took off; this time, he absolutely cannot miss it again.
So they immediately spoke out loudly and clearly in support of Duke. Duke.
The others also started discussing it intensely.
The situation was about to spiral out of control when Albert slammed his fist on the table again.
"Alright, it seems everyone is in agreement. I also support Duke. Duke's view."
"The collaboration with the Broad Institute will continue, but for now it will be limited to the development of Thalassemia Gene Drug. Anyway, it's almost finished, and the project can't be canceled."
"As for other drug development projects, they can be used if they want. The company only looks at the results and does not impose any restrictions."
Then, he looked at Andre in the crowd and gave him an encouraging smile.
"Andre, you and Mr. Wei have always had a good relationship. I'll leave the patent licensing fee to you. I'm confident you can negotiate a satisfactory price."